Position paper - Strengthening Member State cooperation on Health Technology Assessment

The American Chamber of Commerce to the EU (AmCham EU), which represents companies operating across the life sciences sector, supports the European Commission’s proposal on Health Technology Assessment (HTA) in its aim to harmonise the assessment of clinical evidence and avoid duplication of HTA processes across EU Member States. Fostering timely patient access to effective, safe and reliable treatments is at the centre of this objective, a priority shared by our member companies. In this regard AmCham EU encourages the Commission to adopt a balanced approach and methodology reflecting the specificities of each sector of the healthcare industry, in line with the principles outlined in this paper.

Please contact Ava Lloyd, Policy Manager (ava@amchameu.eu), with any questions.